Welcome to our dedicated page for RB news (Ticker: RB), a resource for investors and traders seeking the latest updates and insights on RB stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RB's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RB's position in the market.
RB Global (NYSE & TSX: RBA) reported solid Q2 2024 results, with net income available to common stockholders increasing 30% year-over-year to $100.7 million. Despite a 1% decrease in GTV to $4.1 billion, the company saw a 7% increase in service revenue to $859.1 million and an 11% rise in Adjusted EBITDA to $342.0 million. Diluted earnings per share grew 29% to $0.54, while diluted adjusted EPS rose 15% to $0.94. The company has updated its full-year 2024 outlook, projecting GTV growth of 0% to 2% and Adjusted EBITDA between $1,220 to $1,270 million. RB Global also announced a 7% increase in quarterly dividend to $0.29 per share.
